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INTRODUCTION
Cervical cancer is the third most common cancer
and the fourth leading cause of cancer in the world.
It is estimated that 530,000 women diagnosed
with cancer and 275.000 of them died in 2008
around the world.1,2 The development of cervical
cancer is very difference between developed
countries and developing countries. Globally, there
were approximately 85% of cases and 88% of
deaths from cervical cancer in developing
countries.3 In countries that do not have a good
screening program, most of the cervical cancer
patients came at an advanced stage, and in an
incurable stage.4 It is estimated that 50-80% of
sexually active women will be infected with HPV
in their life, and 80% will be free of infection within
2 years and will not cause cancer.4,5 Cervical can-
cer is the only cancer that can be detected early
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Abstrak
Tujuan: Untuk mengetahui tingkat kesesuaian antara pemeriksaan
HPV mandiri dari spesimen vagina dan hasil pemeriksaan sitologi ber-basis cairan dari spesimen serviks.
Metode: Penelitian cross-sectional dilakukan pada cairan serviksdan vagina dari 90 pasien lesi pra-kanker pada April sampai Sep-
tember 2016. Pemeriksaan sitologi dilakukan dengan pemeriksaan
diri dan teknik sitologi berbasis cairan. Pemeriksaan genotip HPVdilakukan dengan teknik PCR. Data dianalisis dengan SPSS.
Hasil: Sebagian besar perempuan dalam penelitian ini berusia >35
tahun (89%), 78% (71/90) multiparitas dan 74,4% (67/90) tidak
mengetahui tentang skrining HPV. Tipe HPV risiko tinggi yangditemukan pada cairan vagina dan serviks adalah tipe 16, 18, 33 dan
45 sedangkan tipe 35 hanya ditemukan pada cairan vagina. Tipe HPV
risiko tinggi yang dominan untuk kedua spesimen adalah tipe 16 dan18. HPV tipe 42 dan 53 adalah HPV risiko rendah yang ditemukan
pada baik spesimen vagina maupun serviks. Kappa Cohen untuktingkat kesesuaian antara pemeriksaan mandiri dan sitologi
berbasis cairan menunjukkan korelasi kuat (r = 0,864).
Kesimpulan: Metode pemeriksaan HPV secara mandiri sendiri dapat
digunakan sebagai pemeriksaan primer deteksi lesi kanker serviks se-
lain sitologi berbasis cairan dengan hasil yang sama.
[Maj Obstet Ginekol Indones 2018; 6-4: 253-256]
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and inhibit its development.
The most important thing in HPV examination
is the accuracy and level of conformity of examina-
tion results. There are currently several types of
methods for detecting HPV infections in the genital
tracts such as conventional Pap smears, visual
inspection with acetic acid (IVA), HPV DNA testing
with cervical smears and tests of vaginal swabs.6
This study aimed to determine conformity of
human papillomavirus between self-examination
of vaginal fluid and cervical specimen with fluid-
based cytology in precancerous lesions.
METHODS
This cross-sectional study was performed on
cervical and vaginal fluid from 90 pre-cancerous
lesions patients from April to September 2016
at Dr. Wahidin Sudirohusodo Hospital and its
affiliated hospitals in Department of Obstetrics
and Gynecology, Faculty of Medicine Universitas
Hasanuddin. Cytological sampling performed with
self-examination and liquid-based cytology
technique. HPV genotyping performed with PCR
technique (primer system MY09-MY11 (MY09/11)
WI LTS-06 method) at the Kalbe Genomics
(KalGen) Laboratory Jakarta Indonesia. Data were
analysed with SPSS. This study was approved by
the Health Research Ethics Committee of the
Faculty of Medicine, Universitas Hasanuddin.
RESULTS
In the present study, self-examination and liquid-
based HPV cytology were performed on 90 pa-
tients with precancerous lesions. Most of the
women aged >35 years (89%), 78% (71/90)
multiparity and 74.4% (67/90) do not know about
HPV screening (Table 1).
Table 1. Samples Characteristic
Characteristic (n=90) n %
Age (years)
20-34 10 11.1
>35 80 88.9
Parity
Nulliparity 19 21.1
Multiparity 71 78.9
Knowledge about HPV screening test
No 67 74.4
Conventional pap smear 23 25.6
High risk and low-risk HPV types were found
both in the vagina and the cervix. High-risk type
found in both specimens were type 16, 18, 33 and
45 whereas type 35 found only in vaginal fluid. The
most prevalent high-risk HPV for both specimens
were type 16 and 18. HPV type 42 and 53 were
the low-risk HPV found in the vaginal and cervical
specimens (Table 2). Cohen’s kappa for inter-test
agreement was 0.864 (Table 3).
Table 2. HPV Type in Vaginal and Cervical Specimen
HPV Vagina Cervix Vagina and cervix
n % n % n %
High risk
16 31 34.4 30 33.3 30 33.3
18 22 24.4 30 33.3 21 23.3
33 3 3.3 2 2.2 2 2.2
45 7 7.8 6 6.7 6 6.7
35 1 1.1 - - - -
Low risk
42 9 10 9 10 8 8.9
53 7 7.8 6 6.7 6 6.7
Table 3. Concordance of HPV Type between HPV Self-sampling and Liquid-based Cytology
HPV self­sampling Liquid­based cytology Total r p
High­risk HPV (n) Low­risk HPV (n)
High-risk HPV 49 5 54
0.864 0.000Low-risk HPV 1 35 36
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DISCUSSION
Age is a major factor in HPV infection in cervical
cancer. The prevalence of women aged 20s infected
with high and low-risk HPV between 20%-40%.7
The study also found that the highest HPV type 16
infection occurs at age 25-40 years compared to
HPV type 18 for the same age group then the risk
of infection decreases with age.8,9 Women aged >35
years with pre-cancerous lesions in the present
study higher than women aged 20-34 years with
the same diagnosis. A study by Sanner et al., found
that 40% of women who do not participate in the
screening programs in Sweden prefer to perform
self HPV examination making this examination
could reduce the incidence of cervical cancer by 25-
50% in postmenopausal women.10
We included sexually active women aged 20-55
years in our study. Sexually active young women
would have a positive HPV test result, and 20s was
the limit age for cervical cancer screening based on
the pathogenesis of the disease. However, high-risk
HPV type 16/18 decreases with age at diagnosis.
Approximately 70% of young women newly
infected with HPV and infection clearance occurs
after 12 months whereas the age of 55 years
decreased the effectiveness of cytological examina-
tion is known to decline in the elderly age group.
A Randomized Trial in Screening to Improve Cyto-
logy (ARTISTIC) also found that the prevalence of
HPV decreased 40% in age 20-24 years, 12% (35-
39 years), and 7% (>50 years). Abnormal biopsy
examination represents CIN 1 and CIN 2/3. These
criteria based on the manifestation of low-grade
histological changes (CIN 1) in new high-risk HPV
infection. This change is usually temporary, while
in CIN 2/3 acts as a precursor of cervical cancer.
High-grade CIN 2/3 lesions along with risk factors
will increase the incidence of persistent high-risk
HPV infection whereas the latest pap smear exami-
nation (last for three months) and histopathology
are the last diagnostic and the gold standard for
the whole examination. This examination directly
impact on the results of diagnostic tests per-
formed.6,11-13
Various methods for detecting and determining
the type of HPV DNA have been widely introduced.
The most commonly used inspection methods are
hybrid capture 2 (HC2) and PCR. In this study, we
used PCR GMP 09/11 method. The use of PCR
methods has been shown to have higher sensitivity
to detect high-risk HPV than HC2. According to one
RCT result, the GPM 09/11 amplification method
shows very low sensitivity (49%).14 Therefore, the
use of similar methods is likely to lead to low levels
of audit sensitivity.
By comparing the health cost effects of some
cervical cancer screening strategies, a positive HPV
test will be followed by cytologic examination. The
combination of cytologic and HPV examinations
simultaneously shows that the use of HPV DNA
testing as a single primary screening tool or in
combination with cytology provides more cost-
effectiveness than primary screening with cytology,
as it may extend the screening interval.15 Based on
the Canadian Cervical Cancer Screening Trial com-
paring the performance of human papillomavirus
(HPV) testing and Papanicolaou cytology in 10.154
samples found that the sensitivity for both tests,
when used at the same time, was 100% and the
specificity was 92.5%.16 Further research by
synergising the existing inspection modalities will
improve diagnostic ability, so the accuracy and
precision of the tool can be as expected. Improving
the validity of the tool, to obtain the lowest
possible false negative value will provide hope for
clinicians to detect earlier an illness, so treatment
and treatment can be given at an earlier stage and
improve the prognosis of the disease.
The accuracy level of conformity with the results
of this examination kappa test indicates that 0.864
results are obtained which means that 86.4% of
results between self-examination and liquid-based
cytology have very strong correlation. In a previous
study assessing the sensitivity and specificity of
diagnostic tests for independent HPV examination
in detecting HPV in high-grade precursor lesions
and cervical cancer showed sensitivity 56% and
specificity 98%. The results showed that the
examination was only able to detect 56% of the
abnormal group, and if the negative results of this
examination 98% ensure the absence of disease.
The study had negative predictive value of this
examination for only 68% and positive predictive
value of 96%. Based on these results, it can be said
that self-examination has the ability to ensure the
positive results of 96%, but the use of examination
tools as an early detection tool requires high
negative false results. The accuracy of this diagnos-
tic test is 79%. These results indicate that 79% of
the results of the tests performed have the con-
formity of the results with the standard of all sam-
ples. Briefly stated that if a person is diagnosed
negatively with HPV self-examination, then the
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possibility to get negative results in the pathologi-
cal findings is 98%.
CONCLUSION
The degree of conformity of HPV vaginal self-
examination and cervical fluid-based cytology in
pre-cancerous lesions has suitability with very
strong categories so that the HPV self-examination
method can be used as a primary examination of
cervical cancer lesions detection in addition to
fluid-based cytology with the similar results.
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